Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Research and Development Grants

University of Guelph

$87,000.00

Characterization of controlled release formulations of novaluron

FY 2011-12

Summary
Mosquitoes pose a serious risk to public health around the globe as vectors of pathogens, such as the West Nile virus, that cause major human diseases. Since 2002, about 34000 cases of West Nile viral infection have been reported in Canada and the USA. Infection by West Nile virus can lead to serious illness resulting in hospitalization and sometimes death in humans. Since mosquitoes are the vectors of this virus, it is extremely important to control mosquito populations especially at their breeding sites, i.e., standing water systems. A number of pesticides including novaluron, a member of benzoylphenyl urea family are effective at controlling mosquitoes. Pestalto, a Canadian pesticide company, has developed slow release wax-based formulations of novaluron in the form of CRD (controlled release device) and a pastille, which regulate the release of the active ingredient in standing water. However, the fate of these formulations in water with various physical and chemical properties is unknown. In order to commercialize these formulations, it is extremely important to understand the effects of various parameters of water such as pH, salinity, water hardness, organic matter and temperature on the bio-availability of novaluron when formulated as CRDs. Therefore, Pestalto has initiated collaborative research with 1. C. Hall, University of Guelph, to characterize these CRD formulations using a GLP (Good Laboratory Practices) study plan. The overall goal of this research is to evaluate and quantify the concentration of novaluron eminating from these slow release formulations under the above-mentioned conditions. We intend to quantify the concentration of novaluron in water samples using advanced HPLC (High Performance Liquid Chromatography) and novel ELISAs (Enzyme-Linked Immunosorbent Assays) developed in Dr. Hall's laboratory. The determination of the bio-available concentration of novaluron in the slow release formulations will assist in the development of environmentally safe mosquito larvae control strategies thereby reducing the transmission of West Nile virus in Canada as well as other mosquito transmitted diseases around the globe.
Program
Collaborative Research and Development Grants
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
394783-2009
Name nom
Hall, Christopher
Department département
Environmental Sciences, School of
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2009
Award amount
87000
Program id
CRDPJ
Program nane en
Collaborative Research and Development Grants
Program name fr
Subventions de recherche et développement coopérative
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1209
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Agriculture
Area of application fr
Agriculture
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
2
Nb partie
2
Application title
Characterization of controlled release formulations of novaluron
Keyword
NSERC
Application summary
Mosquitoes pose a serious risk to public health around the globe as vectors of pathogens, such as the West Nile virus, that cause major human diseases. Since 2002, about 34000 cases of West Nile viral infection have been reported in Canada and the USA. Infection by West Nile virus can lead to serious illness resulting in hospitalization and sometimes death in humans. Since mosquitoes are the vectors of this virus, it is extremely important to control mosquito populations especially at their breeding sites, i.e., standing water systems. A number of pesticides including novaluron, a member of benzoylphenyl urea family are effective at controlling mosquitoes. Pestalto, a Canadian pesticide company, has developed slow release wax-based formulations of novaluron in the form of CRD (controlled release device) and a pastille, which regulate the release of the active ingredient in standing water. However, the fate of these formulations in water with various physical and chemical properties is unknown. In order to commercialize these formulations, it is extremely important to understand the effects of various parameters of water such as pH, salinity, water hardness, organic matter and temperature on the bio-availability of novaluron when formulated as CRDs. Therefore, Pestalto has initiated collaborative research with 1. C. Hall, University of Guelph, to characterize these CRD formulations using a GLP (Good Laboratory Practices) study plan. The overall goal of this research is to evaluate and quantify the concentration of novaluron eminating from these slow release formulations under the above-mentioned conditions. We intend to quantify the concentration of novaluron in water samples using advanced HPLC (High Performance Liquid Chromatography) and novel ELISAs (Enzyme-Linked Immunosorbent Assays) developed in Dr. Hall's laboratory. The determination of the bio-available concentration of novaluron in the slow release formulations will assist in the development of environmentally safe mosquito larvae control strategies thereby reducing the transmission of West Nile virus in Canada as well as other mosquito transmitted diseases around the globe.
University of Guelph - $87,000 Grant (2011-12) | Canada Spends